Rubella is an acute infectious disease caused by Rubella virus (RUBV). RUBV remains an important pathogen worldwide, causing approximately 100 000 cases of congenital rubella syndrome (CRS) every year; and the most severe consequence of rubella is teratogenicity. The aim of this study was to estimate the prevalence of RUBV IgG antibodies and determine RUBV genotypes in Congolese pregnant women in Kongo central province, Democratic Republic of Congo (DRC).
This was a prospective cross-sectional study that consisted of a laboratory analysis of blood samples from 78 pregnant women to check for the presence of RUBV IgG antibodies, and also determine RUBV genotypes in seropositive samples (using primers targeting RUBV nucleoprotein), with the use of serological and molecular methods, respectively. Participants were pregnant women attending antenatal care clinics (ANC) at two health zones of Kisantu town in DRC. They were followed-up from the first to third trimester. Those who were negative for RUBV antibodies at the initial assay (first trimester) were tested in the second and, eventually, the third trimester.
An overall rubella seroprevalence of 58.97% was observed, whereas RUBV nucleoprotein was detected in 60% of randomly selected 30 blood samples among the 46 RUBV seropositive pregnant women. Five (27.77%) of positive samples were positive for both RUBV genotypes (RV8633/9112 and RV8945/9577), whereas 11 (61.11%) of them were positive for RV8633/9112 and two (11.11%) were positive for RV8945/9577 only. Regarding rubella clinical signs and complications, two subjects (2.56%) presented with fever, whereas five pregnant women (6.41%) had experienced abortion. None (0%) of the participants has been vaccinated against RUBV.
Findings from this study suggest that RUBV is prevalent in Congolese pregnant women. Further research is required to elucidate the molecular epidemiology of RUBV in order to design a rational rubella surveillance and control program in DRC.
Chantler J, Wolinsky JS, Tingle A. Rubella virus. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2001. p. 963–90.
Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;85(9984):2297–307. CrossRef
World Health Organization (WHO). Manual for the laboratory diagnosis of measles and rubella virus infection (WHO, 2007). http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_rub_en.pdf. Accessed 21 Feb 2015.
Centers for Disease Control and Prevention (CDC). Global measles and rubella laboratory network. Morb Mortal Wkly Rep. 2005;54:1100–4.
Best JM, Banatvala JE. Rubella. In: Principles and practice of clinical virology, 3rd Edition, 1994; pp. 363-400.
Corcoran C, Hardie DR. Seroprevalence of rubella antibodies among antenatal patients in the western cape. S Afr Med J. 2005;95(9):688–90. PubMed
Goodson JL, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Coshi S, et al. Rubella epidemiology in Africa in the prevaccine era, 2002-2009. Journal of Infectious Disease. 2011;204(1):S215–25. CrossRef
World Health Organization (WHO). Strategic plan for measles and congenital rubella infection in the European region (WHO, 2007). http://www.euro.who.int/document/e81567.pdf. Accessed 21 Feb 2015.
Central Intelligence Agency. Democratic Republic of the Congo. https://www.cia.gov/library/publications/the-world-factbook/geos/cg.html. Accessed 22 Feb 2015.
Schoub BD, Harris BN, McAnerney J, Blumberg L. Rubella in South Africa: an impending Greek tragedy? S Afr Med J. 2009;99:515–9.
World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system, 2010 global summary. Geneva, Switzerland: World health Organization Dept of Immunization, Vaccines and Biologicals; 2010. Reported estimates of measles containing vaccination coverage. In: WHO publication WHO/IVB/2010 R296-349. http://apps.who.int/iris/bitstream/10665/70535/1/WHO_IVB_2010_eng.pdf. Accessed 22 Feb 2015.
Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr J Med. 2004;23(3):245–8. PubMed
National Institute of Statistics of Cameroon. Demographic, health and multiple Indicators Survey (EDS-MICS 2011; French report). http://www.dhsprogram.com/pubs/pdf/FR260/FR260.pdf. Accessed 22 Feb 2015.
- Rubella Seroprevalence and real-time PCR detection of RUBV among Congolese pregnant women
Makola Kennedy Mbanzulu
Nlandu Roger Ngatu
Dimosi Roger Wumba
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II